CurrentRheuma
Get Weekly

Topic · page 10 of 11

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

Briefs 361–400 of 430 placed here, newest publication first

Briefs in Inflammatory myopathies

Newest publication first

  1. Rheumatology (Oxford)

    Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

    Diagnostic or prognostic study

  2. Rheumatology (Oxford)

    Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications

    Cohort study

  3. Rheumatology (Oxford)

    The diagnostic value of urinary N-terminal fragment of titin for skeletal muscle damage in idiopathic inflammatory myopathy

    Diagnostic or prognostic study

  4. Rheumatology (Oxford)

    TWEAK and Fn14 are overexpressed in immune-mediated necrotizing myopathy: implications for muscle damage and repair

    Mechanistic study

  5. Rheumatology (Oxford)

    IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis

    Mechanistic study

  6. Clin Exp Rheumatol

    Two emerging phenotypes of atypical inclusion body myositis: illustrative cases

    Cohort study

  7. Clin Exp Rheumatol

    Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction

    Cohort study

  8. Clin Exp Rheumatol

    Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohort

    Cohort study

  9. Clin Exp Rheumatol

    The diagnostic value of serum YKL-40 for myocardial involvement in immune-mediated necrotising myopathy

    Diagnostic or prognostic study

  10. RMD Open

    Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I

    Mechanistic study

  11. Ann Rheum Dis

    Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

    Mechanistic study

  12. Arthritis Rheumatol

    Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population

    Cohort study

  13. RMD Open

    Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study

    Cohort study

  14. Rheumatology (Oxford)

    Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

    Cross-sectional study

  15. Rheumatology (Oxford)

    High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis

    Cohort study

  16. Arthritis Res Ther

    Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data

    Cohort study

  17. Rheumatology (Oxford)

    The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders

    Cross-sectional study

  18. Rheumatology (Oxford)

    Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5

    Cohort study

  19. Lancet Rheumatol

    Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

    Randomized controlled trial

  20. Arthritis Care Res (Hoboken)

    Cessation of Immunomodulatory Medication Use in Dermatomyositis: A Single‐Center Cohort Study

    Cohort study

  21. Clin Exp Rheumatol

    Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience

    Cohort study

  22. Rheumatology (Oxford)

    WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease

    Case-control study

  23. RMD Open

    Pain in autoimmune inflammatory myopathies: a scoping review

    Research article

  24. Semin Arthritis Rheum

    Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies

    Cohort study

  25. RMD Open

    Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis

    Cohort study

  26. Ann Rheum Dis

    Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies

    Mechanistic study

  27. Arthritis Care Res (Hoboken)

    Long‐Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis‐Specific Autoantibodies: A Single Cohort Study

    Cohort study

  28. Rheumatology (Oxford)

    A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients

    Mechanistic study

  29. Clin Exp Rheumatol

    Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis

    Cohort study

  30. Rheumatology (Oxford)

    Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis

    Cohort study

  31. Semin Arthritis Rheum

    Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group

    Diagnostic or prognostic study

  32. Rheumatology (Oxford)

    B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies

    Mechanistic study

  33. Clin Exp Rheumatol

    Predictors of mortality for dermatomyositis patients positive with anti-melanoma differentiation-related gene 5 and optimal treatment

    Cohort study

  34. Clin Exp Rheumatol

    Intensive induction therapy combining tofacitinib, rituximab and plasma exchange in severe anti-melanoma differentiation-associatedprotein-5 antibody-positive dermatomyositis

    Cohort study

  35. Rheumatology (Oxford)

    Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study

    Cohort study

  36. Clin Exp Rheumatol

    Anti-MDA5-positive dermatomyositis and remission in a single referral centre population

    Cohort study

  37. Rheumatology (Oxford)

    Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin

    Cohort study

  38. Arthritis Care Res (Hoboken)

    Incidence, Prevalence, and Mortality of Dermatomyositis: A Population‐Based Cohort Study

    Cohort study

  39. Clin Exp Rheumatol

    Efficacy and safety of abatacept for interstitial lung disease associated with antisynthetase syndrome: a case series

    Cohort study

  40. Clin Exp Rheumatol

    Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study

    Cohort study

All 430 Briefs in ExploreShowing Briefs 361–400 of 430, newest first